WHO ICTRP trial

The efficacy of PRP and HPE injection in combination with subcision on the…

IRCT20250503065585N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20250503065585N1
Public title The efficacy of PRP and HPE injection in combination with subcision on the atrophic scar of cutaneous leishmaniasis
Scientific title The efficacy of PRP and HPE injection in combination with subcision on the atrophic scar of cutaneous leishmaniasis , a comparative add –on study
Primary sponsor Mashhad University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Countries Iran (Islamic Republic of)
Conditions Condition 1: leishmania scar. Condition 2: leishmaniasis scar. Cutaneous leishmaniasis;B55.1
Interventions Intervention 1: Control group: 3 sessions of subcision with a 28-gauge needle as a treatment for leishmaniasis scar at an interval of one month. Intervention 2: Intervention group1: 3 sessions with an interval of one month, subcision along…
Registration date May 22, 2025
Target size 48
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations